Angiodynamics Inc. (UG2)
Munich
Real-time Data
06:00 AM
Day's Range
10.4052 wk Range
7.15Overview - UG2 - Angiodynamics Inc.
Key Statistics
Valuation
P/E (Trailing)
‪-15.45‬
PEG Ratio
‪-0.19‬
Price / Book
‪3.31‬
Profitability
Gross Margin
‪54.00%‬
Profit Margin
‪54.62%‬
Operating Margin
‪-6.97%‬
Return on Assets
‪-13.75%‬
Return on Equity
‪-21.50%‬
Ownership
Shares Outstanding
41.70M
Price stats
50-Day Avg
‪12.04‬
200-Day Avg
‪10.36‬
Peers - UG2 - Angiodynamics Inc.
Peer Comparison
Compared with companies in Medical Instruments & Supplies listed on Munich.
- UG2MunichAngiodynamics Inc.+34.45%52-week change-13.52P/E (Trailing)‪54.62%‬Profit Margin
- 6L8MunichPulse Biosciences, Inc.+50.39%52-week change-23.70P/E (Trailing)‪-54.00%‬Profit Margin
- S5U5MunichSafilo Group S.p.A.+36.53%52-week change14.62P/E (Trailing)‪60.94%‬Profit Margin
- 1MDMunichModern Dental Group Ltd.+35.95%52-week change1.40P/E (Trailing)‪55.79%‬Profit Margin
- WPSMunichWest Pharmaceutical Services, Inc.+30.49%52-week change44.15P/E (Trailing)‪35.91%‬Profit Margin
- EP3MunichOrasure Technologies Inc.+29.95%52-week change—P/E (Trailing)—Profit Margin
- 6XTMunichAsahi Intecc Co., Ltd.+26.43%52-week change—P/E (Trailing)‪67.68%‬Profit Margin
Profile Summary - UG2 - Angiodynamics Inc.
About
AngioDynamics Inc. is a medical technology company that designs, manufactures, and sells medical, surgical, and diagnostic devices for treating peripheral vascular disease, oncology, and surgical applications in the United States and internationally. The company focuses on restoring healthy blood flow in the body's…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
